CD1D and neuroblastoma: In addition, Dr. Metelitsa’s group investigated tumor associated macrophages (TAMs) in neuroblastoma and found that while CD1d+TAMs can promote tumor growth, TAMs can also present neuroblastoma antigens that can lead to their recognition and killing by NKT cells [79].